Study guide

8.2 Saudi National Immunization Schedule & Well-Child Care

Saudi Medical Licensing Examination SMLE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Overview & Foundation of Clinical Practice

1.1 Exam Format, Blueprint & Preparation Strategy 1.2 Medical Bioethics, Patient Safety & SCFHS Regulations 1.3 Biostatistics & Clinical Epidemiology in Saudi Healthcare

2 Chapter 2: Internal Medicine - Cardiovascular & Respiratory Systems

2.1 Coronary Artery Disease, Dysrhythmias & Heart Failure 2.2 Respiratory Failure, Asthma, COPD & Infiltrative Lung Diseases 2.3 Critical Care Medicine, Shock Syndromes & Mechanical Ventilation

3 Chapter 3: Internal Medicine - Gastroenterology, Renal & Endocrine Systems

3.1 Hepatobiliary Disorders, Peptic Ulcers & Inflammatory Bowel Disease 3.2 Acute Kidney Injury, Chronic Kidney Disease & Electrolyte Imbalances 3.3 Diabetes Mellitus, Thyroid Disorders & Adrenal Axis Pathologies

4 Chapter 4: Internal Medicine - Infectious Diseases, Hematology & Subspecialties

4.1 Saudi Regional Infections (MERS-CoV, Brucellosis, TB, Dengue) & Antimicrobial Therapy 4.2 Hemoglobinopathies (Sickle Cell & Thalassemia), Anemias & Hematologic Malignancies 4.3 Connective Tissue Diseases, Stroke, Epilepsy & Movement Disorders 4.4 Psychiatry, Geriatrics & Behavioral Health

5 Chapter 5: Obstetrics - Antepartum & Intrapartum Care

5.1 Routine Prenatal Care, Screening & Fetal Assessment 5.2 Placental Disorders, Bleeding in Pregnancy & Isoimmunization 5.3 Normal Labor, Malpresentation, Operative Delivery & Fetal Monitoring

6 Chapter 6: Obstetrics - High-Risk Complications & Postpartum Care

6.1 Preeclampsia, Eclampsia & HELLP Syndrome 6.2 Preterm Labor, Premature Rupture of Membranes & Cervical Insufficiency 6.3 Postpartum Hemorrhage, Puerperal Infections & Maternal Mortality

7 Chapter 7: Gynecology & Reproductive Health

7.1 Menstrual Disorders, Endometriosis & Fibroids 7.2 Infertility Workup, Contraception & Menopause 7.3 Cervical, Uterine & Ovarian Neoplasms

8 Chapter 8: General Pediatrics, Neonatology & Development

8.1 Developmental Milestones, Growth Charts & Failure to Thrive 8.2 Saudi National Immunization Schedule & Well-Child Care 8.3 Neonatal Resuscitation, Jaundice, Respiratory Distress & Prematurity

9 Chapter 9: Pediatric Medicine - Respiratory, Cardiac & GI

9.1 Croup, Epiglottitis, Bronchiolitis, Asthma & Cystic Fibrosis 9.2 Congenital Heart Disease (Cyanotic & Acyanotic) & Rheumatic Fever 9.3 Dehydration, Gastroenteritis, Intussusception & Pyloric Stenosis

10 Chapter 10: Pediatric Medicine - Infections, Hematology, Emergencies & Subspecialty Systems

10.1 Exanthems, Meningitis, Sepsis & Febrile Seizures 10.2 Pediatric Sickle Cell Vaso-occlusive Crises, Thalassemia & ITP 10.3 Pediatric Trauma, Ingestion, Poisoning & Child Abuse Recognition 10.4 Pediatric Neurology, Nephrology & Musculoskeletal Disorders

11 Chapter 11: General Surgery & Surgical Principles

11.1 Preoperative Risk Assessment, Wound Healing & Surgical Infections 11.2 Fluid Resuscitation, Acid-Base Disturbances & Surgical Shock 11.3 Acute Abdomen, Appendicitis, Hernias, Gallbladder & Colorectal Surgery

12 Chapter 12: Trauma, Critical Care & Surgical Emergencies

12.1 ATLS Primary/Secondary Survey, Thoracic & Abdominal Trauma 12.2 Thermal/Chemical Burns, Parkland Formula & Wound Management 12.3 Breast Masses, Thyroid Nodule Evaluation & Surgical Oncology

13 Chapter 13: Surgical Subspecialties

13.1 Nephrolithiasis, BPH, Prostate Cancer & Increased Intracranial Pressure 13.2 Common Fractures, Compartment Syndrome & Pediatric Orthopedics 13.3 Epistaxis, Red Eye Emergencies, Peripheral Vascular Disease & Aortic Aneurysms

8.2 Saudi National Immunization Schedule & Well-Child Care

Key Takeaways Explain This Topic AI

The Saudi National Immunization Schedule recommends BCG and Hepatitis B vaccines at birth to protect against endemic tuberculosis and vertically transmitted hepatitis.

Hexavalent vaccine (DTaP, Hib, HepB, IPV) is administered at 2, 4, and 6 months of age to streamline dosing and improve compliance.

Live attenuated vaccines (e.g., MMR, Varicella, OPV) are generally contraindicated in severely immunocompromised children and pregnant individuals.

Well-child visits in Saudi Arabia emphasize not only immunizations but also vision and hearing screening, developmental surveillance, and nutritional counseling.

The MenACWY conjugate vaccine is a crucial component of the Saudi schedule given at 9 and 12 months due to the region's unique risks associated with Hajj.

Last updated: July 2026

Saudi National Immunization Schedule & Well-Child Care

Preventive pediatrics and immunization constitute high-yield material on the SMLE. Candidates must possess exact knowledge of the Saudi Ministry of Health (MOH) National Immunization Schedule, vaccine types, valid vs. false contraindications, cold chain storage standards, the Saudi Newborn Screening Program, and well-child anticipatory guidance.

The Saudi National Immunization Schedule

The Saudi MOH mandates a comprehensive immunization schedule for all children born in the Kingdom. Memorizing the precise age milestones and vaccine combinations is essential:

Age Target Vaccines Administered (Saudi MOH Schedule) Clinical Considerations & Specifics

At Birth BCG (Bacillus Calmette-Guérin) + Hepatitis B (Dose 1) BCG given ID in left arm (prevents TB meningitis). HepB IM in anterolateral thigh.

2 Months Hexavalent (DTaP-Hib-HepB-IPV) + PCV13 (Dose 1) + Rotavirus (Dose 1) Hexavalent combines 6 antigens in 1 injection. Rotavirus is oral.

4 Months Hexavalent (Dose 2) + PCV13 (Dose 2) + Rotavirus (Dose 2) Second primary dose series.

6 Months Hexavalent (Dose 3) + PCV13 (Dose 3) + OPV (Dose 1) OPV (Oral Polio Vaccine - bivalent) added to boost mucosal IgA.

9 Months Single Measles + MenACWY (Meningococcal Conjugate, Dose 1) MenACWY is unique to KSA due to Hajj/Umrah mass gatherings.

12 Months MMR (Dose 1) + PCV13 (Booster) + OPV (Dose 2) + MenACWY (Dose 2) Transition to live MMR vaccine.

18 Months Pentavalent (DTaP-Hib-IPV) + OPV (Booster) + MMR (Dose 2) + Varicella (Dose 1) + Hepatitis A (Dose 1) Comprehensive 1.5-year booster visit.

24 Months Hepatitis A (Dose 2) Completes Hepatitis A series (minimum 6 months after dose 1).

4-6 Years (School Entry) DTaP (Booster) + OPV (Booster) + MMR (Booster) + Varicella (Booster) Required for elementary school registration in KSA.

  • Classification of Vaccines & Absolute Contraindications
  • Live-Attenuated Vaccines

Contain weakened living pathogens capable of replicating. Examples: BCG, Rotavirus, OPV, Single Measles, MMR, Varicella .

Absolute Contraindications:

Severe Primary or Acquired Immunodeficiency: Severe Combined Immunodeficiency (SCID), advanced HIV/AIDS, patients on high-dose systemic immunosuppressive therapy (e.g., prednisone ≥2 mg/kg/day for >14 days), or biologics (anti-TNF agents). Giving live vaccines to immunocompromised patients risks fatal disseminated infection.

Pregnancy: Live vaccines are contraindicated due to potential fetal transmission.

Specific Rotavirus Contraindication: History of Intussusception or uncorrected congenital GI malformation (e.g., Meckel's diverticulum).

Inactivated, Subunit & Conjugate Vaccines

Contain killed pathogens or purified antigens. Examples: IPV, HepB, HepA, DTaP, Hib, PCV13, MenACWY .

Absolute Contraindications: Anaphylaxis or severe systemic allergic reaction to a previous dose of the specific vaccine or vaccine component (e.g., yeast allergy for Hepatitis B vaccine; neomycin/gelatin allergy for MMR/Varicella).

Encephalopathy within 7 days of DTP/DTaP: Contraindicates future pertussis-containing vaccines; substitute DT.

Valid vs. False Contraindications (High-Yield SMLE Traps)

The following conditions are NOT CONTRAINDICATIONS to receiving vaccines. Withholding vaccines for these reasons represents sub-standard care:

Mild acute illness (e.g., low-grade fever, mild upper respiratory infection, mild diarrhea).

Current antimicrobial / antibiotic therapy.

Prematurity (premature infants receive vaccines at the same chronological age as full-term infants, using full standard doses).

Local injection site reactions (erythema, swelling) to a prior dose.

Family history of adverse events, sudden infant death syndrome (SIDS), or autism.

Vaccine Storage & Cold Chain Management

Cold chain failure invalidates vaccine efficacy and can induce adverse events.

Refrigerated Vaccines (2°C to 8°C / 36°F to 46°F): DTaP, Hib, HepB, HepA, IPV, PCV13, MenACWY, Rotavirus. (Must NEVER be frozen; freezing destroys aluminum adjuvants).

Frozen Vaccines (-50°C to -15°C): Varicella, MMRV. (Protect from light).

OPV Storage: Stored frozen at -20°C for long-term storage; thawed to 2°C–8°C for clinical use.

Saudi National Newborn Screening Program

The Saudi Ministry of Health mandates universal newborn screening for all infants born in KSA hospitals. Screening is performed via a dried blood spot (heel prick test) collected between 24 and 72 hours of life (after protein feeding is established).

High-Yield Inborn Errors of Metabolism (IEM) Screened in KSA

The program screens for 17 congenital metabolic and endocrine disorders:

Congenital Hypothyroidism: Screened via TSH. Prevents irreversible intellectual disability ( cretinism ) if Levothyroxine is started within the first 2 weeks of life.

Congenital Adrenal Hyperplasia (CAH): 21-hydroxylase deficiency screened via 17-hydroxyprogesterone (17-OHP) . Prevents fatal salt-wasting crisis (hyponatremia, hyperkalemia, shock) and evaluates ambiguous genitalia in females.

Phenylketonuria (PKU): Deficiency of phenylalanine hydroxylase. Screened via blood phenylalanine levels. Treatment: Phenylalanine-restricted diet.

Maple Syrup Urine Disease (MSUD): Deficiency of branched-chain alpha-keto acid dehydrogenase. Leads to accumulation of leucine, isoleucine, valine. Classic sweet maple syrup odor of urine and cerumen; rapidly causes neonatal encephalopathy and seizures.

Galactosemia: Deficiency of galactose-1-phosphate uridyltransferase (GALT). Presents with jaundice, hepatomegaly, cataracts, and E. coli neonatal sepsis after milk ingestion. Treatment: Soy formula (lactose-free).

G6PD Deficiency & Hemoglobinopathies: Screened in endemic regions.

Well-Child Physical Exam & Anticipatory Guidance

Developmental Dysplasia of the Hip (DDH): Physical examination at every well-child visit up to 12 months:

Ortolani Test: Abduction of hip with gentle anterior pressure relocates a dislocated femoral head back into acetabulum (positive: palpable "clunk").

Barlow Test: Adduction of hip with posterior pressure dislocates an unstable femoral head out of acetabulum.

Imaging Standard: Ultrasound of hips is the modality of choice for infants <4-6 months (radiographs used after 6 months when femoral head ossifies).

Red Reflex Examination: Performed in a darkened room using an ophthalmoscope. A white pupillary reflex ( Leukocoria ) mandates immediate pediatric ophthalmology referral to rule out Retinoblastoma or congenital cataracts.